 |
Therapy Insight: Metabolic and Endocrine Disorders in Sickle-cell Disease CME DisclosuresRelease Date: January 23, 2008; Valid for credit through January 23, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| The content of this CME activity, "Therapy Insight: Metabolic and Endocrine Disorders in Sickle-cell Disease," was developed by the faculty.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
Sickle cell disease is an autosomal recessive hemoglobinopathy characterized by abnormal hemoglobin production, hemolytic anemia, and intermittent occlusion of small vessels with resulting ischemia, organ damage, and dysfunction. In the United States 1 in 12 African Americans carries the sickle cell gene, and 1 in 375 has sickle cell anemia with 2 million heterozygous carriers. Therapy Insight: Metabolic and Endocrine Disorders in Sickle-cell Disease
Dawn Smiley, MD
Samuel Dagogo-Jack, MD, FRCP
Guillermo Umpierrez, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the prevalence of sickle cell disease and its carrier state among US African Americans
- Identify the clinical features and treatment of sickle cell disease
- Describe the most accurate test for the assessment of
iron overload in sickle cell disease
- List predictors of iron overload and diabetes mellitus in patients with sickle cell disease
- Describe the most common types of endocrine and metabolic disorders seen in sickle cell disease
Authors and Disclosures |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
